Confidential reports designed to help GPs improve the quality of care, with a focus on prescribing and patient safety, are available for practices that contribute to CPRD.
CPRD and the Royal College of GPs (RCGP) have developed confidential, bespoke drug prescribing reports for individual practices, available for free for GP practices contributing to CPRD. The reports provide a pseudonymised list of patients at the practice so that GPs can re-identify and review their care. Reports also show the practice’s prescription rate benchmarked against other participating GP practices. Each report covers a selection of safety indicators and enables collection of evidence for annual appraisals under Domain 2 (Safety and Quality). Unlike much of the performance measurement information that a practice receives, this report is for practice-use only and is not made available in the public domain. Below you can view examples, created using sample data, for the following reports: GPs are invited to take an active role in suggesting indicators for future reports. Further information is available on the RCGP website, where you can view videos by Dr Scott Jamieson, RCGP Scotland Quality Improvement lead, providing an overview of the data reports and how they can be used by practices. On the NIHR website you can view a blog by Dr Tommy Hunter about how he has used a report at his own practice. The latest report is on prescribing of valproate to women of childbearing potential. Managing the prescription of psychotropic medication for adults with learning disabilities, autism, or both in order to minimise potential negative impacts is a challenging process for primary care. In order to support GPs and primary care pharmacists with this, reports include the following indicators: These indicators are based on NHS England's Stopping Over-Medication of People with a Learning Disability, Autism or Both (STOMP) project, which aims to improve the quality of life of people with a learning disability, autism or both by reducing the potential harm of inappropriate psychotropic drugs. For each of the indicators, the reports: The heart and circulatory system QI report includes three indicators taken from the RCGP patient safety toolkit and one that was suggested by NICE: Below you can view an example report, created using sample data. Further information For more information about the reports email gpnetwork@mhra.gov.uk or call 020 3080 7206. Publication:
To receive the reports, practices must be contributing to CPRD. 
Prescribing of valproate to women of childbearing potential
Patient safety and prescribing in patients with a learning disability, autism or both
Heart and circulatory system reports
[Page last reviewed 31 March 2020]
